Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

Nearly every massive winner has one thing in common: low-volume retests that scare out weak hands. Ross Haber buys constructive shakeouts at key moving averages instead of chasing extended green bars. Buying low-volume weakness gives you a tight, low-risk entry. Buy constructive weakness, not extension.

13,161 görüntüleme • 4 gün önce •via X (Twitter)

2 Yorum

Azraël profil fotoğrafı
Azraël4 gün önce

@RossHaber Low volume retest entries are clean because the option market usually prices the pullback as noise. Implieds stay soft while spot shakes out, so a tight spread near the MA costs almost nothing if you're wrong.

Stratist | The Strat profil fotoğrafı
Stratist | The Strat3 gün önce

@RossHaber Which video is this on YouTube?

Benzer Videolar

Here are 3 simple patterns to master trading so you can be ready for the market's next uptrend: → Expectation breakers → Upside reversals → Inside days A very timely walkthrough with Richard Moglen and to get your weekend started. — Timestamps: 00:00 – Shakeouts and false signals: why not all setups are valid 01:18 – Expectation breakers: spotting surprise reversals in real time 03:14 – Reading price bars: closing range, volume, and market intent 06:00 – Relative strength in corrections: what Nvidia taught us 07:36 – Pattern psychology: reversals, breakouts, and failed moves 09:58 – Setting expectations: interpreting short-term price action 12:41 – Entry tactics: inside days, reversals, and tight risk setups 15:00 – Failed breakouts and the importance of bigger picture context 17:20 – Using multiple timeframes to confirm market direction 18:16 – Priming the range: setups that hint at explosive momentum 22:01 – Trade execution: context, levels, and timing precision 23:46 – Price–volume strategy: breakout conviction vs. weak pullbacks 26:11 – Bar-by-bar analysis: how pros study past winners 29:14 – Case study: RKLB’s full breakout-to-failure cycle 34:21 – Identifying sell signals through failed expectations 38:12 – Volume churn vs. low-volume tightness: which wins? 39:49 – Final takeaways: trading psychology, discipline, and edge 41:13 – Chart replay practice: mastering price action in real time Enjoy 💪

TraderLion

31,562 görüntüleme • 1 yıl önce

"Taking An Aspirin Everyday To Prevent A Heart Attack Is Wrong, Dangerous & Can Be Deadly." Dr Jack Wolfson, Cardiologist "A Daily Aspirin Is A Lie That's Been Fed To Us For Over 50 Years." "Aspirin Does Not Protect You Or Fix Your Damaged Arteries...It Just Makes You Bleed." Almost 30 million Americans take aspirin for primary or secondary prevention of cardiovascular disease (CVD) or colorectal cancer (CRC). For decades, low dose Aspirin has been prescribed to patients as primary prevention for patients at risk for CVD, but has now been withdrawn as a line of treatment or prevention. The most recent recommendations from the US Preventive Services Task Force (USPSTF) have abandoned the routine call for daily aspirin use because of the harms that daily low dose aspirin causes. Research From The ARRIVE, ASPREE & ASCEND Peer Reviewed Studies, Confirms That Daily Aspirin, Even Low Dose 'Baby Aspirin,' Is Harmful & Causes Major Bleeding: More than 46,000 adults were studied for multiple years on low dose enteric coated 100 mg aspirin & found significant major bleeding while also finding no benefit for cardiovascular disease. The causal factor of the increased risk of bleeding is aspirin inhibits platelet activity as a COX-1 inhibitor, which damages the protective layer of gastrointestinal mucosa, intracranial brain tissue & micro bleeding anemia. 1⃣ Increased risk of major bleeding: This includes gastrointestinal (GI) bleeding (e.g., ulcers, bleeding in the stomach or intestines) & intracranial hemorrhage (bleeding in the brain), which can be severe & life-threatening. 2⃣ Hemorrhagic stroke: Aspirin increases the risk of hemorrhagic strokes, where a blood vessel bursts in the brain. Bleeding events were 38% higher among participants who were taking aspirin daily, regardless of their gender, age, or cardiovascular risk. 3⃣ Anemia: The ASPREE trial, showed 20% increase in Anemia, characterized by low red blood cell counts & symptoms like fatigue & weakness. Slow micro bleeding anemia as low Hemoglobin iron & Ferritin levels plummeting to less than 45 mcg/L. 4⃣ Gastrointestinal damage: Aspirin, even at low doses, causes damage to the lining of the stomach & intestines, leading to erosions, ulcers & bleeding. Research participant data showed 60% had major GI bleeds as a result of a daily low dose aspirin. 👇ASCEND Aspirin Bleeding Risk Study👇 👇Daily Low Dose Aspirin Causes Anemia👇 👇ASPREE Low Dose Aspirin Causes GI Bleeding👇 Speaker: Dr Jack Wolfson, MD

Valerie Anne Smith

209,973 görüntüleme • 1 yıl önce